Timber Creek Capital Management LLC Acquires 6,760 Shares of Revvity Inc. (NYSE:RVTY)

Timber Creek Capital Management LLC raised its holdings in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 20.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 40,177 shares of the company's stock after purchasing an additional 6,760 shares during the quarter. Timber Creek Capital Management LLC's holdings in Revvity were worth $4,251,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also bought and sold shares of the company. IFM Investors Pty Ltd lifted its holdings in shares of Revvity by 6.1% in the 1st quarter. IFM Investors Pty Ltd now owns 25,959 shares of the company's stock valued at $2,746,000 after acquiring an additional 1,484 shares during the last quarter. Teacher Retirement System of Texas purchased a new stake in Revvity during the first quarter valued at approximately $1,884,000. Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in shares of Revvity by 2.4% in the 1st quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,458 shares of the company's stock valued at $1,424,000 after purchasing an additional 310 shares during the last quarter. Amalgamated Bank boosted its holdings in shares of Revvity by 1.0% in the 1st quarter. Amalgamated Bank now owns 23,777 shares of the company's stock worth $2,516,000 after purchasing an additional 227 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of Revvity by 11.1% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 13,415 shares of the company's stock worth $1,417,000 after purchasing an additional 1,343 shares during the period. Institutional investors own 86.65% of the company's stock.

Revvity Price Performance

NYSE:RVTY opened at $101.31 on Friday. Revvity Inc. has a one year low of $87.70 and a one year high of $129.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.99 and a current ratio of 3.58. The firm has a market cap of $11.94 billion, a price-to-earnings ratio of 43.11, a PEG ratio of 2.54 and a beta of 0.98. The firm's fifty day moving average is $93.90 and its two-hundred day moving average is $104.99.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings results on Monday, April 28th. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.96 by $0.05. The company had revenue of $664.76 million during the quarter, compared to the consensus estimate of $662.30 million. Revvity had a return on equity of 7.73% and a net margin of 10.35%. Revvity's revenue for the quarter was up 2.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.98 earnings per share. Research analysts expect that Revvity Inc. will post 4.94 EPS for the current year.

Revvity Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be given a dividend of $0.07 per share. The ex-dividend date is Friday, July 18th. This represents a $0.28 annualized dividend and a yield of 0.28%. Revvity's dividend payout ratio is presently 11.91%.

Analysts Set New Price Targets

Several research firms have recently issued reports on RVTY. JPMorgan Chase & Co. lowered their target price on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a report on Tuesday, April 29th. Barclays dropped their target price on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. Robert W. Baird cut their price target on Revvity from $127.00 to $125.00 and set an "outperform" rating on the stock in a report on Tuesday, April 29th. Raymond James Financial reiterated an "outperform" rating and issued a $120.00 target price (down from $145.00) on shares of Revvity in a report on Tuesday, April 29th. Finally, Wells Fargo & Company lowered their target price on shares of Revvity from $130.00 to $102.00 and set an "equal weight" rating for the company in a research note on Thursday, April 17th. Four investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $123.64.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.